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β-N-methylamino-L-alanine (BMAA) is a neurotoxic amino acid produced by most 
species of cyanobacteria. Exposure to BMAA has been hypothesized as a cause of 
ALS and possibly Parkinson’s and Alzheimer’s diseases for several decades. Both in 
vitro and in vivo experiments revealed that exposure to elevated concentrations of 
BMAA can damage motor neurons and cause motor dysfunctions. However, the exact 
mechanism of BMAA-induced neurotoxicity has not been well understood. 
Based on the available literature and in spite of its water-soluble and non-protein 
nature, BMAA appears to be able to bioaccumulate in organisms. The ubiquity of 
cyanobacteria and the potential for bioaccumulation of BMAA, arouse wide human 
health concern. Previous investigations into toxicity of BMAA mainly focused on 
various mammalian test models, including rats, mice and primates. However, the toxic 
effect of BMAA on aquatic organisms has attracted limited attention. Due to the 
potential for widespread BMAA production in aquatic ecosystems, it is important to 
understand the toxicity of BMAA in aquatic organisms, such as fish, from an 
ecotoxicological perspective 
Because limited information exists about how exposure to BMAA influences fish, we 
 
 
investigated the acute toxic effect of β-N-methylamino-L-alanine (BMAA) on two 
widely adopted model fish: fathead minnow (Pimephales promelas) and zebrafish 
(Danio rerio). The 96 h toxicity tests revealed that BMAA is not acutely lethal to 
fathead minnow (juveniles: 96 h LC50 > 10 mg/L; larvae: 96 h LC50 > 10 mg/L) or 
zebrafish (larvae: 96 h LC50 > 10 mg/L; embryos: 10-day LC50 > 100 mg/L) at 
concentrations well above those reported in the literature. However, exposure to 
BMAA at 100 mg/L significantly affected the heart rate of zebrafish embryos. 
Additionally, in the zebrafish embryo-larvae behavioral assay, a range of locomotor 
function anomalies in zebrafish embryo-larvae exposed to BMAA were observed. On 
one hand, BMAA was found to accelerate the onset of spontaneous contractions and 
enhanced touch-evoked contractions. On the other hand, BMAA reduced performance 
in touch-evoked escape, free swimming and startle response. 
To our knowledge, we are the first to investigate the acute toxicity of BMAA in 
fathead minnow and its behavioral effects on fish. The finding that BMAA influenced 
locomotor behaviors of fish is of both neurotoxicological and ecological importance. 
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CHAPTER ONE. LITERATURE REVIEW 
1.1 β-N-methylamino-L-alanine (BMAA)  
1.1.1 ALS/PDC and the discovery of BMAA 
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a 
progressively debilitating, fatal disease caused by the degeneration of the motor 
neurons (Rowland and Shneider, 2001). Although evenly distributed in most areas of 
the world (Bradley and Mash, 2009), ALS has three high-incidence epicenters in 
Guam, the Kii Peninsula of Japan, and west New Guinea, where it is often 
accompanied with Parkinson’s disease (PD) and dementia (Vyas and Weiss, 2009). 
The incidence of ALS/Parkinson - dementia complex (ALS/PDC) on Guam was 
unnaturally higher (approximately 100 times) than elsewhere at its peak in 1950’s 
(Arnold et al., 1953; Garruto and Yase, 1986; Prasad and Kurland, 1997), leading to a 
worldwide concern and a high interest in finding the etiology of the disease on this 
island (Arnold et al., 1953; Koerner, 1952; Mulder et al., 1954).  
After ruling out genetic factors (Kurland and Mulder, 1954), the investigators 
turned to link ALS/PDC to special environmental conditions on Guam or unique 
habits of indigenous Chamorro people (Reed et al., 1987). Soon, an unusual 
traditional diet of Chamorros to eat food such as tortillas, soups and dumplings made 
from native cycad (Cycas micronesica Hill) seed flour became a popular research 
subject until the early 1970’s (Lythgoe and Riggs, 1949; Nishida et al., 1955; Whiting, 
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1964; Whiting et al., 1966). Although no successful lab animal models of ALS were 
established in cycad material toxicity tests (Laqueur et al., 1963; Levene et al., 1964; 
Mickelsen et al., 1964), a new amino acid of potential neurotoxicity, 
β-N-methylamino-L-alanine (BMAA), was isolated from cycad seeds in 1967 (Vega 
and Bell, 1967; Whiting, 1988). 
The discovery of BMAA benefited from the original attempt to find 
β-N-oxalylaminol-L-alanine (BOAA), a known neurotoxin responsible for paralytic 
disease lathyrism with symptoms similar to ALS/PDC (Bell, 2009; Rao et al., 1964). 
Instead of BOAA, BMAA was incidentally found in cycad seeds and gradually 
became a widely studied potential cause of ALS/PDC (Bradley et al., 2009; Chiu et al., 
2011; Pablo et al., 2009; Spencer et al., 1987). 
1.1.2 Structure and biochemistry of BMAA 
β-N-methylamino-L-alanine (BMAA) is a small non-protein amino acid 
(NPAA), with a chemical formula of C4H10N2O2 and a molecular weight of 118.13 
(Dossaji and Bell, 1973; Jonasson et al., 2008). BMAA is structurally an alanine with 
a methylated amino group on β-carbon (Figure 1.1), which is similar to another 
neurotoxic amino acid, β-N-oxalylaminol-L-alanine (BOAA), only with a methyl 
group instead of an oxalyl group (Banack et al., 2007).  
BMAA is a polar base and can be easily dissolved in water. Despite of its 
non-lipophilicity nature, BMAA is capable of bioaccumulating in organisms probably 
by binding to certain proteins in a protein-associated form (Cox et al., 2003; Murch et 
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al., 2004a). Free BMAA can be transformed into protein-associated BMAA during 
protein synthesis, and it can also be slowly released back to free form through acid 
hydrolysis (Murch et al., 2004a; Lopičić et al., 2011). 
1.2 Neurotoxicity of BMAA 
1.2.1 BMAA ALS/PDC hypothesis 
The hypothesis that BMAA caused ALS/PDC was supported by toxicity test 
on chicks soon after its isolation (Vega and Bell, 1967). Both natural and synthetic 
BMAA (i.p., 0.2-0.8 g/kg) caused weakness, inability and discoordination in young 
(1-3 days) chicks (Whiting, 1988).  
Similar tests on rats and mice also confirmed the acute toxicity of BMAA, 
showing symptoms including weakness, convulsion and discoordination (Vega et al., 
1968). However, because only acute and non-progressive toxic effects were observed, 
the hypothesis of BMAA as the causal agent of ALS/PDC was questioned and almost 
excluded (Polsky et al., 1972).  
The “BMAA-ALS/PDC” hypothesis had been seldom mentioned until 1987, 
when a landmark paper reporting the neurotoxicity of BMAA to primates was 
published (Spencer et al., 1987). Based on observing a transitory hyperexcitable state 
with a following long whole-body shake/wobble in mice treated with BMAA (Ross 
and Spencer, 1987), Spencer and colleagues moved on to monkeys and recorded 
many ALS/PDC-like neurodegenerative symptoms, such as shaking and paralysis, in 
male cynomolgus macaques (1 year) fed by BMAA (oral, 0.1-0.3 g/kg per day) for up 
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to 12 weeks. This study presented clinical, neurophysiological and neuropathological 
evidence to support that BMAA could induce a primate motor system disorder 
involving the upper and lower motor neurons and the extrapyramidal system (Spencer 
et al., 1987). 
Although Spencer’s observation was a great breakthrough, the high BMAA 
dose used in his work was criticized by Duncan et al. (1988) and Garruto et al. (1988), 
who at that time believed it was too high for Chamorros to reach the neurotoxicity 
threshold by consuming cycad seeds. 
1.2.2 Bioaccumulation of BMAA 
Due to BMAA’s non-lipophilicity and non-protein nature (Krüger et al., 2010), 
BMAA was initially expected to be readily excreted from the human body after 
ingestion (Strong, 2003). However in 2002, unlike other polar substances, BMAA was 
surprisingly found to bioaccumulate in flying fox bats that fed on cycad seeds on 
Guam (Cox and Sacks, 2002a, 2002b). Murch et al. (2004a) then suggested a 
bioaccumulation mechanism that dissolved BMAA (free BMAA) can be bound to 
proteins in an associated form (protein-associated BMAA), which was proved by 
Cheng and Banack (2009) who detected a high content of protein-associated BMAA 
in cycad seeds. The bioaccumulation capacity of BMAA, together with the fact that 
only free BMAA was measured in early studies (Cheng and Banack, 2009), and the 
fact that flying fox bats were a traditional food of Chamorros (Cox et al., 2003), 
indicated a much lower previous estimation of the BMAA consumption by people on 
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Guam (Chiu et al., 2011).  
The bioaccumulation of BMAA became an important base of the 
BMAA-ALS/PDC hypothesis, because protein-associated BMAA possibly functions 
as an endogenous neurotoxic reservoir that slowly releases free BMAA in human 
bodies. Given that BMAA passes the blood-brain barrier (BBB) (Duncan et al., 1991; 
Kisby et al., 1988; Smith et al., 1992), the gradual release of free BMAA was 
suggested to cause a chronic BMAA exposure in human brains (Murch et al., 2004a). 
This suggestion was corroborated by the discovery of BMAA in brain tissues from 
Chamorro ALS/PDC patients and Canadian Alzheimer’s disease (AD) patients, but 
not in healthy controls (Cox et al., 2003; Murch et al., 2004a, 2004b). The work of 
Pablo et al. (2009) also supported the bioaccumulation of BMAA by finding high 
levels of BMAA in almost all (49 out of 50) brain samples from ALS and AD patients 
in North America.  
It was noteworthy that two other investigations failed to detect any free or 
protein-associated BMAA in Chamorro ALS/PDC victim or US AD victim brains 
(Montine et al., 2005; Snyder et al., 2009). However, the insensitivity of their methods 
was suggested as the cause for a lack of detection (Bradley and Mash, 2009; 
Karamyan and Speth, 2008). 
1.2.3 Experimental evidences of BMAA-induced neurotoxicity 
Based on the inspiring observation of Spencer et al. (1987), as well as the 
finding of BMAA bioaccumulation, a number of BMAA neurotoxicity investigations 
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have subsequently been done in the past three decades. Most investigations, both in 
vivo and in vitro, supported the BMAA-ALS/PDC hypothesis (Banack et al., 2010; 
Chiu, 2011; Karamyan and Speth, 2008; Karlsson et al., 2014; Lopičić et al., 2011; 
Papapetropoulos, 2007; Rodgers, 2014).  
BMAA exposure in vivo caused motor function anomalies such as ataxia, 
rigidity, weakness and convulsion (Chang et al., 1993; Dawson et al., 1998; Matsuoka 
et al., 1993; Rakonczay et al., 1991; Seawright et al., 1990), vacuolization and 
mitochondria dysfunction of spinal cord motor neurons (de Munck et al., 2013b), 
degeneration of hippocampal neurons followed by long-term cognitive function 
deficits (Karlsson et al., 2009c, 2011, 2012), selective damage of cerebellum 
(Seawright et al., 1990), probable damage of dopaminergic terminals (Santiago et al., 
2006), and perturbation of serum metabolism (Engskog et al., 2013) to rats. In vivo 
mice experiments showed motoric impacts of BMAA similar to those in rats (Smith 
and Meldrum, 1990). Al-Sammak (2012), in a 14 day-BMAA exposure (i.p.) test on 
mice, observed a median lethal dose (LD50) of 3 mg/g and symptoms including 
dyspnea, urinary and fecal incontinence, and uncoordinated limb and body movement. 
Other neurotoxic effects of BMAA on mice included acute locomotive activity 
impairments and hyperactivity (Karlsson et al., 2009b), neurodegeneration of 
hippocampal neurons (Buenz and Howe, 2007), and retinal neuron death (Santucci et 
al., 2009).  
Additionally, various in vitro studies also proved the neurotoxicity of BMAA 
by reporting BMAA-induced death of spinal cord (Rao et al., 2006) and cortical 
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neurons in rodents (Lobner et al., 2007; Ross et al., 1987; Weiss and Choi, 1988; 
Weiss et al., 1989).  
It was notable that not all investigations supported the BMAA-ALS/PDC 
hypothesis. Perry et al. (1989) fed 2-month-old female mice with a total dose of 15.5 
g/kg BMAA over 11 weeks; Cruz-Aguado et al. (2006) fed 6 month old male mice 
with daily 28 mg/kg BMAA for 30 days. Although high doses of BMAA were used, 
no behavioral and neuropathological impacts of BMAA were observed in either study. 
However, the lack of toxic effects of BMAA in both works was explained as 
inadequate behavior observation methods and improper dose selection, respectively 
(Karamyan and Speth, 2008). More recently, Lee and McGeer (2012) investigated the 
toxicity of BMAA to three different neuron-derived human cancer cell lines. The 
researchers failed to observe any strong cell damage caused by BMAA exposure and 
concluded that the BMAA-ALS/PDC hypothesis became untenable. However, Chiu et 
al. (2011) questioned their conclusion because the cell lines they used were highly 
proliferative immortalized cells, which are significantly different in physiological 
characteristics from normal neurons in vivo. 
1.2.4 Mechanisms of BMAA-induced neurotoxicity 
Despite the various studies implicating BMAA in ALS/PDC, the exact 
mechanism of its neurotoxicity has not been well understood. The first mechanistic 
BMAA paper was published in 1988 by Weiss and Choi (1988). The authors found 
that the presence of a physiological concentration (≥ 10 mM) of bicarbonate (HCO3
−
) 
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ions greatly enhanced the neurotoxicity of BMAA in vitro. The bicarbonate 
dependency of BMAA might contribute to the formation of a BMAA-carbamate 
(Figure 1.2) that had a structure similar to glutamic acid (glutamate), a well-known 
excitatory amino acid (EAA) (Nunn and O’Brien, 1989; Myers and Nelson, 1990).  
A number of studies have provided evidence that BMAA interacted with 
different EAA receptors and induced excitotoxicity (Chiu et al., 2012): BMAA acted 
as an agonist for NMDA receptors, AMPA receptors and metabotropic glutamate 
receptor 5 (mGluR5), finally promoting neural cell damage (Chiu et al., 2012; Goto et 
al., 2012; Liu et al., 2009; Lobner et al., 2007; Nedeljkov et al., 2005; Rakonczay et 
al., 1991; Weiss and Choi, 1988); BMAA activated non-NMDA ionotropic glutamate 
receptors, causing a decrease of input membrane and an imbalance between 
intracellular [Na
+
] and [K
+
] activity (Lopicic et al., 2009). BMAA was also found to 
produce an in vitro elevation of [Ca
2+
] level (Brownson et al., 2002; Chiu et al., 2012; 
Cucchiaroni et al., 2010; Okle et al., 2013a; Rao et al., 2006), which in brains plays an 
important role in EAA-induced neurotoxicity and cell death (Choi, 1987, 1992; 
Randall and Thayer, 1992; Tymianski et al., 1993).  
In addition, BMAA inhibited the cysteine/glutamate antiporter system Xc
-
 
mediated cystine uptake, leading to decreased cellular glutathione and increased 
oxidative stress in cells (Liu et al., 2009). BMAA-involved oxidative stress was 
supported by various other studies recording a rise of reactive oxygen species (ROS) 
level both in vitro and in vivo (Chiu et al., 2012; Cucchiaroni et al., 2010; de Munck et 
al., 2013a; Okle et al., 2013b; Lobner et al., 2007; Rao et al., 2006; Santucci et al., 
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2009).  
In 2009, Karlsson et al. (2009a) found that BMAA interacted with melanin and 
increasingly accumulated in melanin and neuromelanin containing cells, suggesting a 
possible link between ALS/PDC and its common symptom of pigmentary retinopathy 
(Cox et al., 1989). Nunn and Ponnusamy (2009) also proposed a biochemical 
mechanism of BMAA toxicity in which BMAA reacted non-enzymatically with 
pyridoxal-50-phosphate, releasing methylamine. The formation and release of 
methylamine might be important because chronic exposure to methylamine in rats 
caused oxidative stress (Deng et al., 1998).  
Some more recent findings include: BMAA induced human protein misfolding 
and aggregation by misincorporated into proteins in place of L-Serine, indicating a 
trigger for neurological diseases associated with protein-misfolding including ALS 
(Dunlop et al., 2013; Rodgers and Dunlop, 2011); BMAA enhanced the level of 
β-type glycogen synthase kinase-3 (GSK3β) and TAR-DNA-binding protein 43 
(TDP-43), which were both involved in neurodegenerative diseases (de Munck et al., 
2013b); BMAA caused dysregulation of the cellular protein homeostasis followed by 
endoplasmic reticulum (ER) stress and increasing Caspase 12 cleavage in human 
neuroblastoma cells (Okle et al., 2013a).  
1.3 BMAA in ecosystems 
1.3.1 Sources of BMAA 
Although BMAA has been isolated from endemic Guam cycads (Cycas 
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micronesica Hill) in 1967, its ultimate source in cycads remained unknown for 
decades. In 2003, Cox et al. (2003) first discovered that BMAA was produced by 
nitrogen-fixing cyanobacteria of the genus Nostoc that lived in endosymbiosis with 
specialized coralloid roots of the cycads.  
Cyanobacteria have been well known for their ability to produce a wide range 
of secondary metabolites (Carmichael 1992; Moore, 1996; Namikoshi and Rinehart, 
1996; Welker and Von Döhren, 2006). Many of these by-products are dermal irritants 
and known to affect gastrointestinal tract, liver, or neural system of both animals and 
humans, and known collectively as cyanotoxins (Chorus and Bartram, 2003; Dow and 
Swoboda, 2000; Mohamed, 2008; Stewart et al., 2008). Generally, each of these 
cyanotoxins seems to be produced by only a few species of cyanobacteria (Rippka et 
al., 1979). However, BMAA was reported to be produced by most species of 
cyanobacteria, including symbionts and free-living groups from both terrestrial and 
aquatic environments (Banack et al., 2007; Bidigare et al., 2009; Cox et al., 2005; 
Esterhuizen-Londt et al., 2011a; Roney et al., 2009).  
BMAA belongs to a class of over 900 non-protein amino acids (NPAAs) found 
in nature produced by plants, fungi, and microorganisms (Rubinstein, 2000). Although 
NPAAs have many unknown functions (Vranova et al., 2011), a majority of them 
appear to be nitrogen-storage molecules and potential anti-predation toxins (Karlsson, 
2010). However, limited information exists on the nature and role of BMAA 
production in cyanobacteria (Downing et al., 2011; Berntzon et al., 2013). Recently, 
planktonic diatoms (Jiang et al., 2014) and dinoflagellate Gymnodinium catenatu 
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(Lage et al., 2014) were also suggested to be potential BMAA producers. 
1.3.2 Occurrence of BMAA in diverse environments 
Cox et al. (2005) pointed out that the occurrence of BMAA might not be 
limited to Guam, but be globally distributed due to the ubiquity of cyanobacteria. 
Although there is not enough evidence to prove the ubiquity of BMAA (Faassen, 2014) 
so far, many studies have confirmed the wide extent of BMAA in diverse ecosystems. 
BMAA was found in cyanobacteria samples collected from fresh and brackish 
waterbodies in the British Isles (Metcalf et al., 2008), coastal and open-water areas of 
the Baltic Sea (Jonasson et al., 2010), urban waters in the Netherlands (Faassen et al., 
2009), freshwater impoundments in South Africa (Esterhuizen and Downing, 2008; 
Esterhuizen-Londt and Downing, 2011), arid inland areas (Roney et al., 2009) and 
freshwater lakes (Li et al., 2010; Jiao et al., 2014) in China, and highland lakes in 
Peru (Johnson et al., 2008). Water or planktonic samples from shallow springs of the 
Gobi Desert in Mongolia (Craighead et al., 2009), dams in Brazil (Moura et al., 2009), 
reservoirs in the Midwest United States (Al-Sammak et al., 2013, 2014), west coastal 
marine environments of Sweden (Jiang et al., 2014) and two coastal waterbodies of 
Portugal (Lage et al., 2014) also contained BMAA. In addition to aquatic 
environments, BMAA was detected in dried cyanobacterial crusts and mats from the 
deserts of Gulf region, particularly Qatar (Cox et al., 2009).  
1.3.3 Bioaccumulation of BMAA in wild organisms 
BMAA was previously demonstrated to bioaccumulate in Guam’s cycad seeds 
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and flying fox bats through the food chain from endosymbiotic cyanobacteria (Banack 
and Cox, 2003; Cox and Sacks, 2002a; 2002b; Cox et al., 2003). Therefore, the 
ubiquity of cyanobacteria also suggested that similar situation might occur in other 
environments containing cyanobacteria, especially aquatic ecosystems. 
To investigate the potential for bioaccumulation of cyanotoxins in Nebraska, 
Al-Sammak et al. (2014) examined 72 plant samples and 248 fish samples collected 
from local reservoirs between 2009 and 2010; 15 plant samples and 31 fish samples 
contained BMAA (Al-Sammak et al., 2014). Bioaccumulation of BMAA was also 
detected in zooplankton, mussels, oysters and fish in the Baltic Sea (Jonasson et al., 
2010), shrimp, lobsters, crabs, oysters and fish in South Florida coastal waters 
(Banack et al., 2014; Brand et al., 2010), fish and crocodiles in a South African 
natural freshwater body (Esterhuizen-Londt, 2010), and mollusks, crustaceans and 
fish in Chinese lake Taihu (Jiao et al., 2014).  
In Sweden, BMAA was found in oysters and fish from local fish market 
(Spáčil et al., 2010), as well as mussels on Swedish west coast (Salomonsson et al., 
2013). BMAA was also detected in organs of sharks in South Florida (Mondo et al., 
2012) and commercial shark cartilage (fin) food supplements (Mondo et al., 2014).  
The wide spread occurrence of cyanobacteria-produced BMAA, together with 
its potential for bioaccumulation within different organisms, indicate multiple 
potential paths of human exposure such as direct contact during recreational activities, 
consumption of water and foods, and even inhalation of aerosols and dusts (Banack et 
al., 2010; Stommel et al., 2013). Besides the human health concern, the ubiquity of 
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cyanobacteria also suggests an ecotoxicological concern about the fate and impact of 
BMAA in diverse ecosystems, especially aquatic ecosystems.  
1.4 Ecotoxicity of BMAA 
In order to establish a causative association between BMAA exposure and 
human ALS/PDC, most toxicological tests of BMAA focused on proving its 
neurotoxicity in several mammalian test models such as rats, mice and primates (Chiu 
et al., 2011; Karamyan and Speth, 2008; Lopičić et al., 2011; Rodgers, 2014). 
Compared to these human health risk investigations, quite limited attention has been 
drawn to the ecological risk assessment of BMAA. Bidigare et al. (2009) reported 
possible implications of cyanobacteria and BMAA in avian vacuolar myelinopathy 
(AVM), a neurological disease that produces uncoordinated behavior in affected birds 
in wetland ecosystems of the southeastern United States. Unfortunately, the authors 
provided no toxicological evidences to support such a link (Bidigare et al., 2009). In 
fact, only a few studies involving the ecotoxicity of BMAA exist to date.  
1.4.1 Toxic effects of BMAA on terrestrial organisms 
In 2009, Zhou et al. (2009) reported the toxic effects of BMAA on fruit fly 
(Drosophila melanogaster). Adult fruit flies (0-3 days) were raised on sucrose-agar 
medium mixed with water-dissolved BMAA at a final concentration of 4 mM. Dietary 
intake of BMAA not only reduced lifespan of both male (< 35 days) and female (< 25 
days) fruit flies compared to that of control (> 50 days), but also weakened the 
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climbing performance of both males and females. The authors also found that the 
adverse effects of BMAA could be partly restored by cofeeding with leucine or lysine, 
both of which might share the same transporter system with BMAA on blood-brain 
barrier of fruit flies (Zhou et al., 2009). Zhou and colleagues (2010) continued their 
research on fruit flies but used sucrose-agar media containing different concentrations 
of BMAA (0, 2, 4, 6, 8 or 10 mM). The result again showed that the BMAA-induced 
reduction of lifespan and climbing ability were dose-dependent. Some other effects of 
BMAA on fruit flies were also observed, including BMAA accumulation in brain, 
female fertility decrease and learning and memory ability impairment (Zhou et al., 
2010). 
In work of Goto et al. (2012) using the same Drosophila model, virgin female 
fruit flies (1-3 days) were fed with food pellets containing BMAA (25 mM) for 6 days. 
Starting from 2 days of feeding, fruit flies have gradually exhibited motor 
dysfunctions in standing, walking, climbing, flying, and wing beat. Physiological 
effects of BMAA ingestion were also reported in this study. Postsynaptic response 
abnormalities, such as more rise time, reduced amplitude, and longer duration, of an 
identified glutamatergic cell were detected in fruit flies fed with BMAA, indicating 
that they suffered from intracellular excitotoxicity (Goto et al., 2012).  
Okle et al. (2013a) investigated the toxicity of BMAA on summer bees of the 
European honeybee (Apis mellifera). BMAA (0.625 or 1.25 mM) bath application on 
the bee brains for 30 min lead to the generation of ROS and an increase of antennal 
lobe activity with higher Ca
2+
 level in brain neurons. Feeding bees with sugar water 
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mixed with bee saline containing BMAA (final concentration 5 mM) significantly 
increased the mortality after 24 h and impaired their odor learning ability after 5 days. 
By feeding 
14
C-BMAA, BMAA was found to occur in head and thorax, and 
accumulate in abdomen, of bees with little or no excretion. 
14
C-BMAA was also 
transferred from one bee to another via trophallaxis, resulting in an exposure of the 
whole beehive (Okle et al., 2013a).  
It should be noted that Drosophila and honeybees are both important insect 
models of neuroscience research (Bilen and Bonini, 2005; Menzel and Muller, 1996). 
On one hand, the observations of motor dysfunctions in fruit flies and odor learning 
impairment in honeybees are important proofs of BMAA-induced neurotoxicity. On 
the other hand, the finding that BMAA reduced lifespan and female fertility in fruit 
flies, and that BMAA was transferred among bees via trophallaxis are of ecological 
importance.  
1.4.2 Toxic effects of BMAA on aquatic organisms 
BMAA has been detected in diverse ecosystems, especially aquatic 
ecosystems (Al-Sammak et al., 2014; Faassen, 2014). Given the worldwide increasing 
frequency and magnitude of cyanobacteria blooms (Carmichael, 2001), 
cyanobacteria-produced BMAA might increasingly occur in aquatic ecosystems. Thus, 
there is a need to understand the outcome of BMAA exposure in a variety of aquatic 
organisms. However, using aquatic organisms as the test models is relatively novel in 
BMAA toxicity research. 
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In 2011, Esterhuizen et al. (2011) reported a rapid uptake and accumulation of 
BMAA by lab cultured aquatic macrophyte Ceratophyllum demersum. The same 
group also investigated the effect of BMAA on the oxidative stress responses of C. 
demersum (Esterhuizen-Londt et al., 2011b). In vivo exposure test revealed that 
BMAA (0.5-100 mg/L) had a significant inhibitory effect on all tested oxidative stress 
response enzymes, including superoxide dismutase, catalase, guaiacol peroxidase, 
glutathione peroxidase and glutathione reductase. In contrast, enzymes not related to 
oxidative stress response, such as alcohol dehydrogenase, alkaline phosphatase and 
acetylcholinesterase, were not affected by BMAA (5-500 mg/L) in in vitro binding 
experiment. The authors suggested that one important mechanism of BMAA is to 
induce oxidative stress by inhibiting antioxidant enzymes (Esterhuizen-Londt et al., 
2011b). 
Lürling et al. (2011) explored both acute and chronic toxicity of BMAA to 
Daphnia magna. Although BMAA was not acutely lethal (48 h LC50 > 10,000 μg/L) 
to neonate (< 24 h) Daphnia, it reduced mobility (48 h IC50 40 μg/L) and affected life 
history characteristics such as reproduction and population growth rate. 
Bioconcentration of BMAA was also detected after a 96 h exposure to 100-10,000 
μg/L BMAA in juvenile (> 48 h and < 72 h) Daphnia, and after a 15 days exposure to 
50 and 100 μg/L BMAA in neonates (< 24 h) (Lürling et al., 2011). 
The first paper focusing on the effects of BMAA on aquatic vertebrates was 
published in 2009. Purdie et al. (2009b) showed physiological and morphological 
toxicity of BMAA to the early-life stage development of zebrafish (Danio rerio). 
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BMAA exposure (5-50,000 μg/L) in zebrafish embryo at 6 h post fertilization (hpf) 
for 5 days caused a range of neuromuscular and developmental abnormalities, 
including reduced heart rate, pericardial edema, abnormal spinal axis formation, 
clonus-like convulsions and significant premature point of hatch. According to this 
study, Danio rerio might be a useful model of BMAA toxicity research because of its 
sensitivity to BMAA (Purdie et al., 2009b). 
Purdie’s group then expanded their study on BMAA to two other aquatic 
species besides zebrafish: brine shrimp (Artemia salina) and the protozoan Nassula 
sorex (Purdie et al., 2009a). Responses to BMAA exposure included loss of phototaxis 
for brine shrimp and increased mortality for all species: Danio rerio larvae (10-day 
LC50 10 μg/L), Artemia salina nauplii (24 to 72 h LC50 3,600 to 1,500 μg/L) and 
Nassula sorex (72 h LC50 5,000 μg/L). Artemia salina and Nassula sorex were also 
suggested to be potential models for BMAA investigations because both of them are 
consumers of cyanobacteria (Purdie et al., 2009a).  
In short, BMAA is toxic to several organisms from both terrestrial and aquatic 
environments. Due to the potential global occurrence of BMAA produced by 
ubiquitous cyanobacteria (Cox et al., 2005), extensive ecotoxicity of BMAA might 
exist, especially in aquatic ecosystems. More investigations are needed to evaluate the 
exposure level, biological fate and toxic effects of BMAA on different aquatic 
organisms. 
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CHAPTER TWO: MATERIALS AND METHODS 
2.1 Introduction 
A toxicity test is usually conducted to investigate the toxicity of a substance on 
living organisms, such as primates, rodents, fish, or Daphnia, for either a human 
safety evaluation or an ecological impact assessment (Abbott, 2005; Ecobichon, 1997; 
Guilhermino et al., 2000). In a toxicity test, the toxicity of the test substance is often 
evaluated by measuring its quantifiable effects on exposed organisms at certain 
endpoints such as survival, growth, reproduction, behavior, and metabolism, within a 
certain period of time (Stokes, 2002; Suter, 1990). According to different exposure 
times of test substances, toxicity tests are divided into three types: acute, subacute, 
and chronic (Gupta and Bhardwaj, 2012). Due to its relatively short time and low cost, 
an acute toxicity test is the first test conducted in most cases. An acute toxicity test 
provides a preliminary understanding of the toxic nature of the test substance and 
serves as an information base for further subacute and chronic tests (Akhila et al., 
2007). In an acute toxicity test, the test organisms are usually treated with high doses 
of test substance, in order to cause changes in at least one measurable endpoint within 
a short period of time.  
Mortality rate is one of the most easily observable endpoints in a toxicity test. 
Therefore, the lethality of a substance to test organisms has become an important aim 
of an acute toxicity test (Toth, 1997, 2000). In a toxicity test using aquatic organisms, 
the acute lethality of a test substance is often expressed as the Median Lethal 
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Concentration (LC50), which causes death of 50% of the test organisms. A typical 
aquatic toxicity test for LC50 determination starts with a range-finding test, followed 
by a LC50 test. The range-finding test is aimed at finding a proper range of toxin 
concentrations as a reference for the LC50 test (Carpenter et al., 1974).  
Generally in the range finding test, test organisms are exposed to a test 
substance at 5-6 gradient concentrations (≤ 100 mg/L), spaced by a large factor, such 
as 10. After the exposure, a range from the highest concentration that causes no 
mortality to the lowest substance concentration that causes absolute mortality of the 
test organisms is recorded. In the LC50 test, the test organisms are exposed to 5-6 
gradient concentrations bordered by the range recorded in the range-finding test. After 
the same exposure time, the LC50 value can be calculated from the 
Concentration-Mortality curve for the test substance.  
Besides mortality rate, sub-lethal anomalies of test organisms in development, 
behavior, physiology, and genetics are also widely adopted endpoints in toxicity tests. 
No Effect Concentration (NEC), the highest substance concentration that causes no 
anomalies in the test organism, reflects the threshold concentration of a substance 
before initiating significant toxic effects (van der Hoeven, 1997). Because the actual 
NEC is almost impossible to measure, it is usually estimated from the 
No-Observed-Effect Concentration (NOEC) - Lowest-Observed-Effect Concentration 
(LOEC) interval (Laskowski, 1995). Median effective concentration (EC50) and 
median inhibitory concentration (IC50) are two other common sub-lethal endpoints, 
referring to the substance concentration that induces effects and inhibition, 
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respectively, in 50% of the test organisms (Sebaugh, 2011). NOEC - LOEC, EC50 and 
IC50 endpoints can be investigated along with the LC50 value as important 
supplements to the toxicity of a test substance.  
In aquatic toxicity tests, fish are crucial test models (Harshbarger and Clark, 
1990), not only due to their indispensable roles in aquatic food chains, but also 
because they are an important aquatic food source for humans (Lammer et al., 2009). 
Fish have been used in toxicity tests for more than 150 years (Penny and Adams, 1863, 
as cited in Hunn, 1989). Due to an increasing need for toxicant assessment and 
ecological study in recent decades, a number of valuable fish models, such as fathead 
minnow (Pimephales promelas), zebrafish (Danio rerio), and Japanese medaka 
(Oryzias latipes), have been established and widely used in toxicity or ecotoxicity 
investigations (Ankley and Johnson, 2004; Ankley and Villeneuve, 2006; T. 
Braunbeck et al., 2005; Hatanaka et al., 1982; Hill et al., 2005; McGrath and Li, 2008; 
Örn et al., 2003). Advantages of these fish models include small body size, well 
characterized development/growth process, short maturation/reproduction cycle, high 
fecundity, and high tolerance of different environmental stresses.  
Fathead minnow, a member of the demersal cyprinid family, is broadly 
distributed in temperate waters across North America (Divine, 1968; Eddy and 
Underhill, 1974; Held and Peterka, 1974; Isaak, 1961; Page and Burr, 1991; Zimmer 
et al., 2001), and plays a key role in the regulation of structure and function of aquatic 
ecosystems (Gingras and Paszkowski, 1999; Paszkowski et al., 2004; Scott and 
Crossman, 1973; Zimmer et al., 2002). As a native fish species, fathead minnow has 
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become the most widely studied toxicological fish model in North America (Ankley 
and Villeneuve, 2006), owning one of the biggest aquatic toxicology databases 
(Ankley et al., 2001; Gray et al., 2002; Keddy et al., 1995; Miracle et al., 2003; Sinks 
and Schultz, 2001).  
Zebrafish (Danio rerio), another demersal cyprinid species, is originated from 
the Ganges River system, Burma, Malakka and Sumatra (Eaton and Farley, 1974; 
Engeszer et al., 2007; Talwar and Jhingran, 1991). Zebrafish has been proved to be a 
valuable fish model and used for decades in a variety of toxicity investigations, 
including chemical screening, water quality control, ecotoxicological assays, and 
neurotoxicology studies (Coverdale et al., 2004; Goldsmith, 2004; Goolish et al., 1999; 
Hill, et al., 2005; Hisaoka and Battle, 1958; Laale, 1977; Lele and Krone, 1996; Nagel, 
2002; Parng et al., 2002).  
In the traditional acute fish test (AFT) with an endpoint of lethality, such as 
the LC50 test, exposure to toxic substances is hypothesized to bring fish severe distress 
and suffering (Chandroo et al., 2004; Nagel, 2002). Under the push of the animal 
rights legislations and animal protection organizations, a few alternative test 
approaches have been established, such as the in vitro fish cell assay and in vivo fish 
embryo test (FET) (Babich and Borenfreund, 1991; Bichara et al., 2014; Embry et al., 
2010; Henn and Braunbeck, 2011; Nagel, 2002; Ryan and Hightower, 1994; Tollefsen 
et al., 2006; van den Brandhof and Montforts, 2010). Numbers of in vitro cytotoxicity 
assays using fish cells have been developed in last 30 years (Castaño et al., 2003), and 
they showed a good correlation with in vivo fish test in chemical toxicity level ranking 
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(Kilemade and Quinn, 2003). However, in vitro tests are limited by their inability to 
actually represent natural situations in the whole organism (Fleming, 2007), and 
Segner (2004) also concluded that the in vitro cytotoxicity assay was less sensitive 
than in vivo toxicity test for fish by reviewing previous works. By contrast, in vivo 
FET, especially the zebrafish embryo test, has been proposed to be a promising 
alternative to the traditional AFT (Belanger et al., 2013; Lammer, et al., 2009; Scholz 
et al., 2008; Strähle et al., 2012). McKim (1977) has found that toxic effects on early 
life-stage are able to predict chronic toxicity of a substance, and embryo-larvae and 
early juvenile are the most sensitive stages of fish development. The Zebrafish 
embryo model is ideal for FET because zebrafish develop fast and normally hatch 
within 4 days post fertilization (dpf) at 26 °C (Nagel, 2002). In addition, the 
embryonic development of zebrafish is phenotypically identifiable and has been 
well-described in detail (Berry et al., 2007; Hinton et al., 2005; Kimmel et al., 1995). 
The observation of zebrafish embryonic development can be easily achieved through 
the transparent chorion. The increasing popularity of zebrafish embryo tests also 
benefits from a reliable correlation (R
2
 = 0.854; p = 0.05; n = 56) between the 
zebrafish embryo tests and the traditional AFT, in spite of a prediction weakness 
(Ratte and Hammers-Wirtz, 2003). 
2.2 Chemicals  
β-N-methylamino-L-alanine (BMAA), tricaine methanesulfonate (MS222), 
3,4-dichloroaniline (3,4-DCA) and sodium bicarbonate (NaHCO3) were purchased 
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from Sigma-Aldrich (St. Louis, MO). All other chemicals used were of analytical 
grade quality. BMAA, NaHCO3 and 3,4-DCA stock solutions were all prepared in 
deionized (DI) water (Milli-Q, Millipore, MA) one day before the onset of 
corresponding test and stored at 4 °C. MS222 solutions were freshly prepared before 
use.  
2.3 Test organisms and maintenance  
All test organisms, including fathead minnows (Pimephales promelas) 
juveniles and larvae, and zebrafish (Danio rerio) adults and eggs, were obtained from 
Aquatic Research Organisms (Hampton, NH). Maintenance and testing of organisms 
were all carried out in large growth incubators (Percival model I-35LLVL, Percival 
Scientific, Boone, IA) kept in the Life Science Annex (LScA) at the University of 
Nebraska-Lincoln (UNL), with room temperature, humidity and pressure controlled. 
All glassware used for fish holding were pre-acid-washed with acetic acid soaking for 
at least 24 h and thoroughly rinsed with corresponding dilution water. Dilution water 
was aerated for at least 12 h in growth incubator before use, in order to reach a proper 
temperature and a dissolved oxygen (DO) level of near saturation. After aeration, the 
final pH of dilution water was adjusted to 7.5 (for fathead minnow) or 7.3 (for 
zebrafish) with the addition of 1 M HCl or 1 M NaOH. Water parameters such as DO, 
pH, temperature, hardness and alkalinity were measured every 24 h. If necessary, a 
semi-static water renewal method was applied to prevent DO deficiency and ammonia 
accumulation. The water renewal was handled in a very careful manner to remove 
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most food residues and fish feces without causing much stress in fish. All test 
organisms were observed regularly. Dead fish were removed as soon as observed. 
Abnormal behaviors and the mortality rate of fish were recorded every 24 h. 
2.4 Acute fathead minnow juvenile test 
2.4.1 Lab conditions 
The temperature in the growth incubators was maintained at 20 ± 1 °C and the 
light/dark cycle was set at 16 h/8 h. Both the acclimation and the toxicity test 
chambers were 3.8 L sphere glass fish bowls (Anchor Hocking #25178, Lancaster, 
Ohio). The dilution water was the dechlorinated tap water obtained by use of two 
activated carbon treatment tanks (Culligan, Rosemont, IL). The final pH of the 
dilution water and all other test solutions was adjusted to 7.5. Other lab conditions 
were controlled following the US EPA guidelines (US EPA, 2002).  
2.4.2 Preparation before exposure 
2.4.2.1 Handling of fathead minnow juveniles  
One month old fathead minnow juveniles were shipped by air in a plastic 
container. After arrival, the container was put in the growth incubator for 1-2 h until it 
had a water temperature close to 20 °C. Then the juveniles were randomly selected 
and transferred to acclimation chambers containing 3 L dilution water (< 30 fish/fish 
bowl) using a nylon fish net.  
25 
 
 
2.4.2.2 Acclimation of fathead minnow juveniles  
Before the toxicity test, fish were acclimated under lab conditions for 7 days, 
regularly fed with commercial fish food flakes (TetraMin, Tetra, Blacksburg, VA) 
twice a day. All of the water in each acclimation chamber was renewed every 24 h 
with the help of another acclimation chamber as the “water-change” bowl, in a 
method described as follows: first, a hemispheric fish net was used to cover the mouth 
of the empty “water change” bowl; second, fresh dilution water was added into the 
“water-change” bowl until the fish net bottom was submerged 1-2 cm into the water; 
third, approximate 3/4 of the water in the acclimation chamber was poured out in a 
very gentle and careful manner to prevent the fish from escaping; fourth, the 
remaining water containing the fish in the acclimation chamber was gently poured 
into the “water-change” bowl through the fish net, which had holes big enough for 
feces to pass but small enough to trap the fish safely; then, the acclimation chamber 
was cleaned and refilled with 3 L fresh dilution water; finally, the fish trapped in the 
fishnet were transferred quickly but carefully back to the acclimation chamber.  
2.4.3 Range-finding test 
Fathead minnow juveniles were treated with either the dilution water as the 
control or BMAA. BMAA solutions were freshly diluted from 10 g/L stock solution 
before use.  
Acclimated fathead minnow juveniles (1 month) were randomly selected and 
carefully transferred into test chambers using a fish net. As a result, fathead minnow 
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juveniles were divided into five test groups, exposed to dilution water (control) and 
four gradient concentrations of BMAA (300 μg/L, 1,000 μg/L, 3,000 μg/L and 10,000 
μg/L), respectively. Each test group had one test chamber. Each test chamber 
contained 1 L test solution and 10 fathead minnow juveniles (10 juveniles/1 L test 
solution/test chamber). The total exposure time was 96 h and no feeding was applied 
during the test. The test solution of each test chamber was renewed every 24 h with 
the same renewal method adopted during acclimation; A 10 ml solution sample from 
each test group was taken every 24 h and stored at -20 °C.  
2.5 Acute fathead minnow larvae test 
2.5.1 Lab conditions 
The temperature in growth incubators was maintained at 20 ± 1 °C and the 
light/dark cycle was 16 h/8 h. Both the acclimation and the toxicity test chambers 
were 3.8 L glass fish bowls. The dilution water was the dechlorinated tap water. The 
final pH of dilution water and all other test solutions was adjusted to 7.5. Other lab 
conditions were controlled following the US EPA guidelines (US EPA, 2002). 
2.5.2 Preparation before exposure 
2.5.2.1 Handling of fathead minnow larvae  
Fathead minnow larvae at the age of 5 days post hatch (dph) were shipped by 
air in a plastic container. After arrival, the container was put in the growth incubator 
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for 1-2 h until it had a water temperature close to close to 20 °C. Then, larvae were 
randomly selected and transferred to acclimation chambers containing 3 L dilution 
water (< 30 fish/fish bowl) using a small siphon hose. The siphon was handled in a 
very gentle and careful manner to avoid causing any physical damage to the larvae.  
2.5.2.2 Acclimation of fathead minnow larvae  
Before the toxicity test, fish were acclimated under lab conditions for 7 days, 
regularly fed with commercial larvae diet (Zeigler Larvae AP100 #LD250, Pentair 
Aquatic Habitats, Apopka, FL). Given that most fathead minnow larvae stayed around 
the bottom of the acclimation chamber, a mixture of larvae diet and 1 ml fresh 
dilution water was added into each acclimation chamber so that the larvae diet 
microcapsules could sink slowly to the water bottom. Approximate 3/4 of the water in 
each acclimation chamber was renewed every 24 h using a small siphon hose. The 
renewal method using a fishnet was not adopted in this case because the larvae were 
too small and too vulnerable to netting.  
2.5.3 Range-finding test 
Fathead minnow larvae (12 dph) were treated with either the dilution water as 
the control or BMAA. Before use, the BMAA solutions were freshly diluted from 10 
g/L stock solution.  
After acclimation, fathead minnow larvae (12 dph) were randomly selected 
and transferred into test chambers using a small siphon hose. To prevent the larvae 
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from staying in the siphon hose, the siphon hose had a size that allowed the larvae to 
swim forward in one direction but hardly turn around. As a result, fathead minnow 
larvae were divided into three test groups, exposed to the dilution water (control) and 
two concentrations of BMAA (1,000 μg/L and 10,000 μg/L), respectively. Each test 
group had one test chamber. Each test chamber contained 500 ml test solution and 10 
fathead minnow larvae (10 larvae/500 ml test solution/test chamber). The total 
exposure time was 96 h without feeding. 3/5 of the test solution (300 ml) in each test 
chamber was renewed every 24 h; A 10 ml solution sample from each test group was 
taken every 24 h and stored at -20 °C. 
2.6 Acute zebrafish larvae test 
2.6.1 Lab conditions 
The temperature in growth incubators was maintained at 26 ± 1 °C with the 
light/dark cycle at 16 h/8 h. Both the hatching and the toxicity test chambers were 3.8 
L glass fish bowls. The dilution water was commercial bottled water (Ice Mountain 
100% Natural Spring Water, Nestlé, Stamford, CT) diluted by a factor of two using 
distilled water. Dechlorinated tap water with a high hardness of around 200 mg/L was 
not used in this test because zebrafish are hardness sensitive and prefers soft water 
with hardness less than 50 mg/L. The dilution water had a final pH of 7.3 after 
aeration. The pH of all other test solutions prepared using the dilution water was also 
adjusted to 7.3. Other lab conditions were controlled following the OECD guidelines 
(OECD, 2012). 
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2.6.2 Preparation before exposure 
2.6.2.1 Handling of zebrafish eggs 
Zebrafish eggs were shipped by air in a plastic container soon after 
fertilization, and had an age of less than 24 hpf upon arrival. The container was put in 
the growth incubator for 1-2 h until it had a water temperature close to 26 °C. Then, 
the eggs were transferred into a hatching chamber using an opening-widened 5 ml 
pipette (Pipetman, Gilson, Middleton, WI). 
2.6.2.2 Hatching of zebrafish eggs 
Zebrafish eggs were kept in the hatching chamber for 48 h when more than 90% 
of the eggs hatched. No water renewal was applied during hatching. In order to start 
the BMAA exposure at the early life-stage of zebrafish, the larvae less than 24 h post 
hatch (hph) old were directly used in the toxicity test without accumulation. 
2.6.3 Range-finding test 
Zebrafish larvae were treated with either the dilution water as the control or 
BMAA. Before use, the BMAA solutions were freshly diluted from 10 g/L stock 
solution.  
Newly hatched zebrafish larvae (< 24 hph) were randomly selected and 
carefully transferred into the test chambers using a 25 ml beaker, with as little water 
as possible. A siphon hose seemed less applicable to transfer zebrafish larvae because 
they reacted and escaped much faster than fathead minnow larvae. As a result, 
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zebrafish larvae were divided into three test groups, exposed to the dilution water 
(control) and two concentrations of BMAA (1,000 μg/L and 10,000 μg/L), 
respectively. Each test group had one test chamber. Each test chamber contained 500 
ml test solution and 10 zebrafish larvae (10 larvae/500 ml test solution/test chamber).  
The total exposure time was 96 h. No feeding was applied because zebrafish 
larvae were able to absorb nutrition through yolk sac till 5 dpf (Jardine and Litvak, 
2003; Rubinstein, 2003); 3/5 of the test solution (300 ml) in each test chamber was 
renewed every 24 h using a small siphon hose; A 10 ml solution sample from each test 
group was taken every 24 h and stored at -20 °C.  
2.7 Zebrafish embryo-larvae test 
2.7.1 Lab conditions 
The temperature in growth incubators was maintained at 26 ± 1 °C, with the 
light/dark cycle at 16 h/8 h. The fish care chambers used for acclimation and 
spawning were 20 L (40 cm × 20 cm × 25 cm) glass fish tanks (Aqueon #10005, 
Franklin, WI). The toxicity test chambers were 3.5 ml 24-well tissue culture plates 
(Falcon #353226, Corning, Corning, NY). All plates were pre-saturated with 
corresponding test solutions for at least 24 h to avoid unexpected absorption of 
BMAA. The dilution water was Ice Mountain bottled water diluted by a factor of 2 
using distilled water. The dilution water and all other test solutions had a final pH of 
7.3. Other lab conditions were controlled following the OECD guidelines (OECD, 
2012). 
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2.7.2 Preparation before exposure 
2.7.2.1 Handling of zebrafish embryos 
Zebrafish embryos were shipped by air in a plastic container soon after 
fertilization, and had an age of less than 24 hpf upon arrival. After arrival, the 
container was put in the growth incubator for 1-2 h until it had a water temperature 
~26 °C. Due to the nature of FET, zebrafish embryos (< 24 hpf) were directly used in 
the rang-finding test without accumulation.  
2.7.2.2 Handling of zebrafish adults 
Adult zebrafish (3 males and 6 females) were shipped by air in a plastic bag. 
After arrival, the bag was put in the growth incubator for 1-2 h until its water had a 
temperature close to 26 °C. Then, the adults were transferred into a 20 L fish tank 
containing 16 L dilution water. A sponge filtration-aeration system was applied in the 
tank to maintain a sufficient DO level and to avoid toxic ammonia accumulation. To 
aid bacteria growth in the sponge filter, the sponge filtration-aeration system started 
running three days in water before zebrafish were introduced.  
2.7.2.3 Accumulation of zebrafish adults 
Zebrafish males and females were acclimated together under lab conditions for 
7 days, regularly fed with fish food flakes twice a day. Approximate 3/4 of the water 
in the tank was renewed every 24 h using a mid-size siphon hose (Aqueon #06227, 
Franklin, WI).  
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2.7.2.4 Preparation for spawning 
After the acclimation, zebrafish males were transferred using a fish net into 
another 20 L fish tank also containing 16 L dilution water and a well-functioning 
sponge filtration-aeration system. The males and females were kept separately under 
lab conditions for 7 days, regularly fed with fish food flakes twice a day and frozen 
brine shrimp (Sally’s, San Francisco Bay, Newark, CA) once a day. 1/4 of the water in 
the tank was renewed every 24 h using a mid-size siphon hose. 
2.7.2.5 Spawning 
The fish tank keeping the zebrafish males was selected as the spawning tank. 
On the day before the spawning, zebrafish females were transferred into the spawning 
tank using a fish net 2 h prior to the onset the darkness. After being held together 
overnight, the males and the females started mating and spawning in 2 h after the 
onset of light. To prevent eggs from being consumed, the adults were confined close 
to the surface of water by a pre-installed horizontal nylon mesh submerged 3 cm into 
the water. After the onset of light, a plastic green plant was placed into the tank as 
spawning stimulus (DIN, 2001). The aeration-filtration speed was properly reduced to 
avoiding heavy perturbation of the dilution water.  
2.7.2.6 Collection of eggs 
During the spawning, most eggs freely passed through the mesh and fell onto 
the bottom of the spawning tank. 2.5 h after the onset of light, the zebrafish adults and 
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the mesh were removed from the spawning tank. Then, eggs were siphoned out using 
a small siphon hose and collected in a 1,000 ml beaker. Given that most eggs 
collected were spawned between 1.5 h and 2.5 h after the onset of light, 0 hpf was 
defined here as 2 h after the onset of light. For convenience, zebrafish prior to 96 hpf 
were defined as embryos and fish from 96 hpf to the end of test were defined as larvae. 
Due to the nature of FET, zebrafish embryos (< 1 hpf) were directly used in the LC50 
test and the behavioral assay.  
2.7.3 Range-finding test 
Zebrafish embryos were treated with the dilution water as a negative control 
(nC) or 3,4-DCA as a positive control (pC), or BMAA. Before use, the pC solution 
and the BMAA solutions were freshly diluted from 4 g/L and 10 g/L stock solutions, 
respectively.  
Immediately after arrival, zebrafish embryos (< 24 hpf) were transferred into a 
120 mm Petri dish (Pyrex, Corning, Corning, NY) using an opening-widened 5 ml 
pipette. The embryos in the Petri dish were washed for 30 s using 50 ml dilution 
water. 
The healthy zebrafish embryos (< 24 hpf) were randomly selected and placed 
onto 24-well plates using an opening-widened 200 μl pipette, with as little water as 
possible. As a result, zebrafish embryos were divided into four test groups, exposed to 
four test solutions, respectively: the dilution water (nC), 4 mg/L 3,4-DCA (pC), and 
two concentrations of BMAA (1 mg/L and 10 mg/L). Each test group had one 24-well 
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plate with 10 embryos in 10 wells. These 10 wells occupied the same locations on 
each plate (A1-A5 and B1-B5) and were pre-loaded with 2 ml corresponding test 
solution (1 embryo/2 ml test solution/well). Each plate was covered by a 
low-evaporation lid to attenuate the change of solution volume and concentration due 
to evaporation in the growth incubator. 
In order to start the exposure in all test groups at the same time with minimum 
delay, a pre-exposure method was applied before zebrafish embryos were placed onto 
the 24-well plates. Right after washing, more than double embryos (< 24 hpf) required 
for the test were randomly selected and transferred from the 120 mm Petri dish into 
four 90 mm Petri dishes (> 20 embryos/Petri dish) using an opening-widened 1,000 μl 
pipette. Each of the four Petri dishes was pre-loaded with 20 ml fresh test solution 
corresponding to one of the four plates. After a careful examination under a dissecting 
microscope (Nikon model SMZ-1 ESD, Nikon, Japan) at 35× magnification, 
abnormal embryos were removed and 10 healthy embryos from each Petri dish were 
randomly selected and placed onto the corresponding plate.  
The total exposure time was 10 days with no feeding applied. Half of the test 
solution (1 ml) in each well was renewed every 24 h using a 1,000 μl pipette. A 10 ml 
sample of test solution removed from each test group was taken every 24 h and stored 
at -20 °C.  
All zebrafish were regularly observed under a dissecting microscope. Dead 
zebrafish were removed from the plates as soon as observed. Mortality of a zebrafish 
embryo was determined by coagulation, no tail detachment, no somite formation or no 
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heart beat.  
2.7.4 10-day LC50 test 
In the 10-day LC50 test, zebrafish embryos were treated with the dilution water 
as a negative control (nC) or NaHCO3 as a solvent control (sC), or BMAA + NaHCO3. 
Before use, the sC solution was freshly diluted by the dilution water from 20 M 
NaHCO3 stock solution and the BMAA solutions were diluted by the fresh sC 
solution from 10 g/L stock solution. 
Newly collected zebrafish eggs (< 1 hpf) were transferred into a 120 mm Petri 
dish using an opening-widened 5 ml pipette. The eggs in the Petri dish were washed 
for 30 s using 50 ml dilution water. 
At 3 hpf, the healthy zebrafish embryos were randomly selected and placed 
onto 24-well plates using an opening-widened 200 μl pipette. As a result, zebrafish 
embryos were divided into seven test groups, exposed to seven test solutions, 
respectively: the dilution water (nC), 20 mM NaHCO3 (sC), and five concentrations 
of BMAA (1 mg/L, 3 mg/L, 10 mg/L, 30 mg/L and 100 mg/L). Each test group had 
one 24-well plate with 20 embryos in 20 wells. These 20 wells on each plate occupied 
the same locations (A1-A5, B1-B5, C1-C5 and D1-D5) and were pre-loaded with 1 
ml corresponding test solution (1 embryo/1 ml test solution/well). Additional 4 
embryos were placed in the remaining 4 wells (A6, B6, C6 and D6) on each plate 
pre-loaded with 1 ml dilution water (1 embryo/1 ml dilution water/well) as an internal 
plate control (iC). In the end, all test groups including iC were distributed on plates as 
36 
 
 
shown in Figure 2.1. Each plate was covered by a low-evaporation lid to attenuate the 
change of solution volume and concentration due to evaporation in the growth 
incubator. 
In order to start the exposure in all test groups at the same time with minimum 
delay, a pre-exposure method similar to that described in the range-finding test was 
applied. Briefly, washed zebrafish eggs (< 1 hpf) were randomly selected and 
transferred into seven 90 mm Petri dishes (> 100 eggs/Petri dish for nC and > 40 
eggs/Petri dish for other groups) pre-loaded with 20 ml respective test solutions. At 3 
hpf, unfertilized eggs were removed and 20 healthy embryos from each Petri dish as 
well as 4 embryos (iC) from the Petri dish for nC were randomly selected and placed 
onto the corresponding plate.  
The total exposure time was 10 days without feeding. Half of the test solution 
(500 μl) in each well was renewed every 24 h using a 1,000 μl pipette. 10 ml sample 
of test solution removed from each test group was taken every 24 h and stored at 
-20 °C.  
All zebrafish were regularly observed under a dissecting microscope. Dead 
zebrafish were removed from the plates as soon as observed. Abnormal growth and 
the mortality rate of zebrafish in each test group were recorded every 24 h. Hatching 
time was measured starting at 48 hpf until all embryos hatched. All embryos were 
observed every 3 h under the microscope and the hatching time of each embryo was 
recorded. Heart rate was measured at 72 hpf, 144 hpf and 10 dpf. 10 embryos from 
each test group were randomly selected and individually observed under the 
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microscope. The heart rate of each embryo was calculated by converting the time 
taken for 30 beats to beats per minute (bpm). Body length was measured at 144 hpf 
and 10 dpf. 10 embryos from each test group were randomly selected and the body 
length of each embryo was individually measured with a ruler under the dissecting 
microscope. Sub-lethal endpoints including anomalies in eyes, pigmentation, blood 
circulation, pectoral fins, swimming bladder, yolk sac and pericardia were also 
recorded. For convenience, zebrafish larvae older than 96 hpf were individually 
anesthetized by 10 ml 60 mg/L MS222 in a 55 mm Petri dish before observation. 
After observation, each larva was allowed to recover in 100 ml fresh dilution water 
for 5 s and then transferred back to its corresponding well. 
2.7.5 Zebrafish embryo-larvae behavioral assay 
In the behavioral assay, zebrafish embryo-larvae were treated with the dilution 
water as a negative control (nC) or NaHCO3 as a solvent control (sC), or BMAA + 
NaHCO3. All test solutions were freshly prepared before use from stock solutions 
with the same method described in the 10-day LC50 test. 
Newly collected zebrafish eggs (< 1 hpf) were transferred into a 120 mm Petri 
dish using an opening-widened 5 ml pipette. The eggs in the Petri dish were washed 
for 30 s using 50 ml dilution water.  
At 3 hpf, the healthy zebrafish embryos were randomly selected and placed 
onto 24-well plates using an opening-widened 200 μl pipette. As a result, zebrafish 
embryos were divided into six test groups, exposed to six test solutions, respectively: 
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the dilution water (nC), 20 mM NaHCO3 (sC), and four concentrations of BMAA (0.1 
mg/L, 1 mg/L, 10 mg/L and 100 mg/L). Each test group had one 24-well plate with 20 
embryos in 20 wells which occupied the same locations (A1-A5, B1-B5, C1-C5 and 
D1-D5) on each plate and were pre-loaded with 1 ml corresponding test solution (1 
embryo/1 ml test solution/well). Each plate was covered by a low-evaporation lid to 
attenuate the evaporation in the growth incubator. 
In order to start the exposure in all test groups at the same time with minimum 
delay, a pre-exposure method similar to that described in the 10-day LC50 test was 
applied. Briefly, washed zebrafish eggs (< 1 hpf) were randomly selected and 
transferred into six 90 mm Petri dishes (> 40 eggs/Petri dish) pre-loaded with 20 ml 
respective test solutions. At 3 hpf, unfertilized eggs were removed and 20 healthy 
embryos from each Petri dish were randomly selected and placed onto the 
corresponding plate.  
The total exposure time was 10 days and no feeding was applied during the 
test. Half of the test solution (500 μl) in each well was renewed every 24 h with the 
same renewal method adopted in the 10-day LC50 test. 10 ml sample of test solution 
removed from each test group was taken every 24 h and stored at -20 °C. 
All zebrafish embryos were regularly observed under a dissecting microscope. 
Dead zebrafish were removed from the plates as soon as observed. Only normally 
developed zebrafish were used in the behavior assay. 
39 
 
 
2.7.5.1 Spontaneous contractions 
The first locomotor behavior of zebrafish embryos is spontaneous contractions, 
a series of slow and alternating tail coils occurring at 17-18 hpf (Colwill and Creton, 
2011). After reaching the peak of frequency around 21 hpf, spontaneous contractions 
gradually slow down and almost disappears after 27 hpf (Saint-Amant and Drapeau, 
1998). 
Starting at 16 hpf, embryos were observed under a dissecting microscope until 
all embryos showed spontaneous contractions. The observation was done every hour 
and the onset time of spontaneous contractions for each embryo was recorded. Onset 
of spontaneous contractions for an embryo was determined here as occurrence of at 
least 1 contraction during an observation time of 20 s.  
At 22 hpf, all embryos from each test group were placed in a 55 mm Petri dish 
containing 20 ml fresh dilution water using an opening-widened 200 μl pipette. After 
2 min acclimation, the movements of embryos in 3 min were recorded by a digital 
camera (PowerShot SX260 HS, Canon, Japan). The frequency of spontaneous 
contractions for each embryo was calculated by converting the time taken for 20 
contractions to contractions per minute (cpm). After recording, all embryos from each 
test group were transferred back onto a new 24-well plate pre-loaded with 1 ml 
corresponding fresh test solution and continued the exposure.  
2.7.5.2 Touch-evoked contractions 
Stereotypically, zebrafish embryos show response to mechanical stimuli 
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around 21 hpf, right after the peak of spontaneous contractions (Downes and Granato, 
2006). Touching the head, tail or yolk sac of an embryo triggers 1-3 in situ body 
contractions each containing a rapid tail coil and a following slower relaxation 
(Saint-Amant and Drapeau, 1998).  
In order to measure the touch-evoked contractions of zebrafish embryos more 
easily, all embryos were dechorionated with 2 pairs of very fine forceps at 24 hpf. At 
27 hpf, 10 embryos from each test group were randomly selected and individually 
placed at the center of a 55 mm Petri dish containing 20 ml fresh dilution water using 
an opening-widened 200 μl pipette. After 2 min acclimation, each embryo was 
stimulated by continually touching the head using a soft painting brush hair. The total 
contractions of the embryo in response to 10 touches with at least 5 s intervals were 
counted. Although the spontaneous contractions of zebrafish embryos had a very low 
frequency at 27 hpf (McKeown et al., 2009), the timing of each touch was carefully 
selected to avoid miscounting due to a high similarity between the two behaviors. 
After observation, each embryo was transferred back to the corresponding well and 
continued the exposure.  
2.7.5.3 Touch-evoked escape 
By the end of 2 dpf, dechorionated zebrafish embryos still rested most of time 
with little movement. However, they were able to show escape response to 
mechanical stimuli via high frequency tail contractions. Normally, an embryo touched 
on the head rapidly re-orientates its body direction and swims away from the stimulus 
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(Ahmad et al., 2012).  
At 48 hpf, 10 embryos from each test group were randomly selected and 
individually placed at the center of a 120 mm Petri dish containing 20 ml fresh 
dilution water using an opening-widened 200 μl pipette. The Petri dish was placed 
over an A4 size grid paper covered with 4.5 mm squares. After 2 min acclimation, 
each embryo was stimulated by continually touching the head using a painting brush 
hair. The incidence of the embryo showing escape behaviors in response to 10 touches 
with at least 5 s intervals was counted. The distance that the embryo swam during 
each escape was also measured. The escape distance was estimated from the number 
of squares away from the touching location multiplied by the width of a square (4.5 
mm). To ensure an enough swimming space, the embryo was re-placed to the center 
of the Petri dish after each escape. After observation, each embryo was transferred 
back to the corresponding well and continued the exposure. 
2.7.5.4 Free swimming 
After 4 dpf, zebrafish larvae gradually started spontaneous free swimming in a 
pattern of “beat and glide” after inflation of the swim bladder (Airhart et al., 2007; 
Buss and Drapeau, 2001). At 120 hpf, most larvae were able to free swimming, 
although still in a relatively slow and low-frequency manner. 
At 144 hpf, 12 zebrafish larvae from each test group were randomly selected 
and individually placed in a 55 mm Petri dish containing 10 ml fresh dilution water 
using an opening-widened 1,000 μl pipette. The Petri dish was placed over an A4 size 
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grid paper covered with 4.5 mm squares. After 5 min acclimation, the swimming 
activity of each larva in 3 min was recorded by a digital camera. The total swimming 
distance, the time spent on swimming, the swimming speed, and the incidences of 
freezing bouts and erratic swimming of the larva during the recording were measured. 
Total swimming distance was estimated from the number of squares that the larva 
swan multiplied by 4.5 mm. Swimming speed was calculated from the total 
swimming distance divided by the time spent on swimming. A freezing bout was 
defined here as an entire absence of spontaneous body motion for at least 2 s between 
two swimming movements. Erratic swimming was defined here as a sudden 
transverse shift of body position or a rapid change of swimming velocity (direction 
and speed). The free swimming recording was performed in group of 6 larvae from 
the same test group in 6 respective Petri dishes. After recording, each larva was 
transferred back into the corresponding well and continued the exposure.  
2.7.5.5 Startle response 
Startle response of animals is an unconditioned behavior which reflects the 
integration of sensory and motor functions (Koch, 1999). A startle response, usually 
representing as rapid contractions of body muscles, can be triggered by visual, 
acoustic or tactile stimuli (Bang et al., 2002; J. Best et al., 2010; J. D. Best et al., 
2008). Zebrafish larvae showed no startle response until 5 dpf, when taping the plates 
caused a sudden acceleration of swimming speed. 
At 7 dpf, 10 zebrafish larvae from each test group were randomly selected and 
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placed together in a 55 mm Petri dish containing 20 ml fresh dilution water using an 
opening-widened 1,000 μl pipette. The Petri dish was placed over an A4 size grid 
paper covered with 4.5 mm squares. After 5 min acclimation, the swimming activity 
of larvae in 1.5 min was recorded by a digital camera as the baselines. Subsequently, 
larvae were startled by continually tapping the rim of Petri dish using the head of a 
falling 200 μl pipette tip. The tail of pipette tip was impaled by a horizontal 
thumbtack fixed on top of a flat base, so that the pipette tip could freely rotate in the 
vertical plane. The responses of larvae to 20 taps with 5 s intervals were also recorded 
by camera. The number of squares that each larva swam in 2 s after each tap was 
counted. To ensure the strength consistency of each tap, the pipette tip was dropped 
by the observer from the same horizontal angle of 45°. After recording, all larvae 
from each test group were transferred back onto a new 24-well plate pre-loaded with 1 
ml corresponding fresh test solution and continued the exposure.  
2.7.5.6 Anxiety 
Anxiety of animals can be caused by a number of factors, such as predation, 
environmental changes and drug exposure (Blaser and Gerlai, 2006; Egan et al., 2009; 
Wong et al., 2010). Anxiety of zebrafish can be reliably evaluated by measuring 
thigmotaxis (Peitsaro et al., 2003; Richendrfer et al., 2012; Schnörr et al., 2012). 
Thigmotaxis describes a “centrophobic” behavior in which animals strongly prefer 
staying or moving in close to the wall rather than the center of an apparatus (C. 
Maximino et al., 2010a).  
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The zebrafish larvae used in the anxiety test were from the same batch of 
collected eggs as those used in other behavioral tests, but were reared in different 
apparatus. Right after the exposure started at 3 hpf, the remaining washed eggs in the 
120 mm Petri dish were carefully examined under a dissecting microscope. 
Unfertilized eggs were removed and healthy embryos were transferred to a new 120 
mm Petri dish containing 40 ml fresh dilution water using an opening-widened 200 μl 
pipette. 3/4 of water (30 ml) in the Petri dish was renewed every 24 h using a 5 ml 
pipette and no feeding was applied before the anxiety test. Unhealthy and dead 
zebrafish were removed from the plates as soon as observed.  
At 7 dpf, 42 zebrafish larvae were randomly selected and divided into six test 
groups (7 larvae/ groups), exposed to six test solutions, respectively: the dilution 
water (nC), 20 mM NaHCO3 (sC) and four concentrations of BMAA (0.1 mg/L, 1 
mg/L, 10 mg/L and 100 mg/L). Larvae from each test group were individually placed 
in a 55 mm Petri dish containing 10 ml corresponding fresh test solution using an 
opening-widened 1,000 μl pipette. A 38 mm diameter circle was marked on the 
bottom of Petri dish to divide it into the inner zone and the outer zone (area ratio 1:1). 
The Petri dish was placed over an A4 size grid paper covered with 4.5 mm squares. 
After 10 min exposure, the swimming activity of larvae in 5 min was recorded by a 
digital camera. The swimming performance of each larva was evaluated with the same 
method adopted in the free swimming test. In addition, thigmotaxis of each larva in 
distance and in time was also measured during the recording. Thigmotaxis in distance 
and thigmotaxis in time were defined here as the percentage (%) of the number of 
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squares and the percentage (%) of the time, respectively, that the larva swam in the 
outer zone. The recording was performed in group of 6 larvae from 6 test groups in 6 
respective Petri dishes. After recording, larvae were removed from their test groups to 
avoid recounting.  
2.8 Statistical analysis 
The lethality of BMAA in zebrafish embryo-larvae was analyzed using the US 
EPA Probit Analysis Program_1.5 (Environmental Monitoring Systems Laboratory, 
OH). The 10-day LC50 and its 95% confidence interval were both calculated.  
Developmental and behavioral endpoints analyses were carried out using 
Excel_2010 (Microsoft, Bellevue, WA) and JMP_10.0.2 (SAS, Cary, NC). For each 
endpoint, data were input into Excel to calculate mean of observations and 
the standard error of the mean (SEM) for each test group. One-way analysis of 
variance (ANOVA) and post hoc Dunnett’s test (*p < 0.05; **p < 0.01; ***p < 0.001) 
were performed in JMP to determine significant differences between control and other 
test groups. All data are presented as mean ± SEM. 
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CHAPTER THREE: RESULTS AND DISCUSSION 
3.1 Results 
3.1.1 Acute toxicity of BMAA to fathead minnow and larval zebrafish 
Short term (96-hr) BMAA exposure (up to 10,000 μg/L) neither influenced 
mortality nor caused obvious adverse effects in juvenile and larval fathead minnow 
(Pimephales promelas) or larval zebrafish (Danio rerio). Because none of the three 
test organisms died during respective range-finding tests, final LC50 tests were not 
conducted.  
3.1.2 Acute toxic effects of BMAA to zebrafish embryo-larvae 
3.1.2.1 10-day LC50 
Although no lethality was observed in the range-finding test, one larva 
exposed to 10 mg/L BMAA exhibited weakness, abnormal spine, and entire body 
albinism and edema. Therefore, a final 10-day LC50 test was conducted using BMAA 
with higher concentrations (1-100 mg/L). The result confirmed that BMAA had little 
influence on mortality of zebrafish embryos. By the end of 10-day LC50 test, no 
embryos died in nC group; one embryo died in sC, the 1 mg/L and 100 mg/L BMAA 
groups; 2 embryos died in the 10 mg/L and 30 mg/L BMAA groups; 3 embryos died 
in the 3 mg/L BMAA group. Because only one iC embryo died in the 100 mg/L 
BMAA group, all test groups were accepted and used for LC50 calculation (OECD, 
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2012). 
3.1.2.2 Hatching time 
Embryos started hatching after 48 hpf and most of them hatched by 66 hpf. 
BMAA had no significant influence on the average hatching time of zebrafish 
embryos. The hatching seemed to be slightly accelerated in the BMAA groups which 
had a higher average hatching rate compared to both control groups at all observation 
points before reaching 100%. The maximum difference (30%) between the BMAA 
groups and nC occurred at 57 hpf, when the hatching rates of them were 75% and 
45%, respectively. However, the acceleration was not obvious between the BMAA 
groups and sC, with the maximum hatching rate difference of only 8% at 63 hpf 
(Figure 3.1). 
3.1.2.3 Heart rate 
Zebrafish embryos exposed to BMAA showed a significantly accelerated heart 
rate compared to sC at 72 hpf (Figure 3.2A). The heart rate of embryos from 30 mg/L 
BMAA and 100 mg/L groups were 18% (***p < 0.001; n = 10) and 23% (***p < 
0.001; n = 10) faster than sC (197.28 ± 4.10 bpm), respectively.  
Interestingly, BMAA exposure significantly reduced the heart rate of embryos 
from all five BMAA groups at 144 hpf (Figure 3.2B). The reductions in heart rate of 
embryos compared to sC (228.37 ± 3.47 bpm) were: 10% (**p < 0.01; n = 10) for the 
1 mg/L BMAA group, 9% (**p < 0.01; n = 10) for the 3 mg/L BMAA group, 10% 
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(**p < 0.01; n = 10) for the 10 mg/L BMAA group, 11% (***p < 0.001; n = 10) for 
the 30 mg/L BMAA group, and 20% (***p < 0.001; n = 10) for the 100 mg/L BMAA 
group.  
At 10 dpf, BMAA had no significant effects on heart rate of embryos exposed 
to 10 mg/L and 100 mg/L BMAA. However, heart rates of embryos from the 1 mg/L, 
3 mg/L and 100 mg/L BMAA groups were significantly slower than sC (170.57 ± 
1.70 bpm), with reductions of 14% (***p < 0.001; n = 10), 12% (***p < 0.001; n = 
10) and 8% (*p < 0.05; n = 10), respectively (Figure 3.2C). 
No significant differences were observed between nC and sC groups at all 
observation points (Figure 3.2). 
3.1.2.4 Body length  
Zebrafish larvae had little difference in body length between the BMAA 
groups and controls (Figure 3.3). The average body length of larvae for all test groups 
(n = 7) was 4.21 ± 0.01 cm at 144 hpf and 4.11 ± 0.01 cm at 10 dpf. 
3.1.2 Behavioral effects of BMAA to zebrafish embryo-larvae 
For behavioral endpoints monitored during the embryo life stage, there were 
no significant differences between zebrafish from nC and sC. However, the two 
control groups gradually presented significant differences at the larvae life stage (data 
not shown). Given that nC was not the direct control, only sC was used as the control 
group in all ANOVA and post hoc Dunnett’s tests. 
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3.1.2.1 Spontaneous contractions 
Spontaneous contractions first occurred at 17 hpf, and all embryos showed 
movements by 21 hpf. Exposure to BMAA caused an early onset of spontaneous 
contractions (Figure 3.4A). Embryos from the 100 mg/L BMAA group started to 
show spontaneous contractions at 19.00 ± 0.16 hpf, nearly 1 h earlier (**p < 0.01; n = 
20) than sC (19.88 ± 0.15 hpf).  
At 22 hpf, the average spontaneous contraction rate of zebrafish embryos was 
9.23 ± 0.37 cpm for all test groups (n = 6; except nC). Embryos from the BMAA 
groups had no significant difference in the frequency of spontaneous contractions 
compared to sC (Figure 3.4B). 
3.1.2.2 Touch-evoked contractions 
By 27 hpf, all zebrafish embryos were able to exhibit at least one contraction 
in response to 10 continual touches on the head. The responses of the embryos were 
almost the same between nC (4.00 ± 0.93 contractions/10 touches) and sC (3.90 ± 
0.75 contractions/10 touches). Generally, BMAA enhanced the touch-evoked 
contractions of embryos (Figure 3.5). Approximately twice (*p < 0.05; n = 10) as 
many contractions as sC were observed in the 10 mg/L BMAA group (7.90 ± 1.28 
contractions/10 touches). Although the difference was not significant, touch-evoked 
contractions of embryos in the 0.1 mg/L BMAA group (6.50 ± 1.24 contractions/10 
touches) was 67% higher than sC. Additionally, embryos from the 0.1 mg/L and 100 
mg/L BMAA groups responded 28% and 41% more times than controls, respectively, 
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without significant differences. 
3.1.2.3 Touch-evoked escape 
BMAA exposure affected the touch-evoked escaping behavior of zebrafish 
embryos (Figure 3.6). Embryos from all BMAA groups exhibited an approximately 
30-50% lower incidences of touch-evoked escape movements compared to sC (5.40 ± 
0.85 escapes/12 touches) (Figure 3.6A). Especially, this reduction was significant in 
embryos from the 10 mg/L BMAA group (*p < 0.05; n = 10) and the 100 mg/L 
BMAA groups (**p < 0.01; n = 10), with escape incidences of 2.80 ± 0.47 and 2.67 ± 
0.58 escapes/12 touches, respectively.  
There were no significant differences between the BMAA groups and sC in 
the embryos’ average swimming distance during each escape. However, the average 
escape distances of embryos from four BMAA groups were all approximately 40% 
shorter than sC (2.15 ± 0.38 cm) (Figure 3.6B).  
3.1.2.4 Free swimming 
BMAA exposure resulted in obvious changes in the free swimming activity of 
zebrafish larvae at 144 hpf (Figure 3.7). The total swimming distance of larvae from 
the 1 mg/L BMAA group in 3 min (20.96 ± 4.18 cm) and their swimming speed 
during movements (7.58 ± 1.40 cm/min) were both significantly lower (*p < 0.05 for 
total distance and **p < 0.01 for speed; n = 12) than sC (total distance: 39.86 ± 6.07 
cm; speed: 14.97 ± 1.85 cm/min). Similarly, the swimming performance of larvae 
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from the 100 mg/L BMAA group (total distance: 12.44 ± 2.80 cm; speed: 4.63 ± 0.91 
cm/min) was also significantly reduced (**p < 0.01 for total distance and ***p < 
0.001 for speed; n = 12) (Figure 3.7A). In addition, larvae from the 10 mg/L BMAA 
group had a significant reduction (*p < 0.05; n = 12) in swimming speed (9.09 ± 1.20 
cm/min) and a non-significant 38% reduction in total swimming distance (24.86 ± 
4.39 cm) in comparison with sC (Figure 3.7B). It was notable that the larvae’s 
swimming activity of the 0.1 mg/L BMAA group seemed to be enhanced in spite of 
no statistical significance. Larvae from this group swam 36% longer in distance 
(54.34 ± 6.23 cm) and 25% faster in speed (18.48 ± 2.04 cm/min) compared to sC 
(Figures 3.7A-B). 
During the 3 min swimming, larvae from sC had 2.18 ± 0.63 freezing points, 
28.00 ± 9.87 s freezing time and 2.33 ± 0.47 erratic movements. Larvae from the 
BMAA groups did not significantly differ from each other or sC in performances at 
these three endpoints. However, larvae showed a dose dependent increase from 0.82 ± 
0.30 to 4.58 ± 1.52 in the incidence of freezing points among BMAA groups (Figure 
3.7C). It was also noteworthy that larvae from the 0.1 mg/L BMAA group spent only 
3.18 ± 1.48 s in freezing which was much lower than other BMAA groups and sC 
(Figure 3.7D). Besides, larvae from the 100 mg/L BMAA group had 55-75% less 
erratic movements (0.75 ± 0.30) in comparison with other test groups (Figure 3.7E). 
3.1.2.5 Startle response 
BMAA reduced the startle response of zebrafish larvae at 7 dpf (Figure 3.8). 
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The average distance that larvae from sC swam in 2 s in response to 20 taps was 0.91 
± 0.10 cm. In contrast, the startle responses of larvae from the 10 mg/L BMAA group 
(0.66 ± 0.05 cm/startle) and the 100 mg/L BMAA group (0.71 ± 0.03 cm/startle) were 
both significantly reduced (*p < 0.05, n = 20) (Figure 3.8E). For each BMAA group, 
the swimming distances of larvae in 2 s after each tap are shown in Figures 3.8A-D 
and the curve of 20 responses was compared with sC. No taps generated a 
significantly longer swimming distance of larvae for all BMAA groups. On the other 
hand, 10-18 out of 20 taps resulted in reduced movements for larvae from the BMAA 
groups, in which 1-2 reductions were significantly different. A general trend of 
decreasing swimming distances along continual taps was found in all test groups (n = 
6; except nC) by observing a negative slope of the linear regression line across 20 
responses, indicating larvae’s habituation to startles (Figures 3.8A-D). The startle 
habituation of each larva was defined here as a process that its responses declined 
close to the baseline (normally 0-0.5 cm/2 s). The response curve of each larva was 
first smoothed with a moving average of three consecutive values. Then, the 
habituation process was determined as the series of responses before reaching the 
bottom of the moving average curve. No significant differences existed for larvae 
from different test groups in the number of taps required for startle habituation 
(Figure 3.8F).  
3.1.2.6 Anxiety 
10 min exposure to 0.1-100 mg/L BMAA did not significantly influence the 
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swimming activity and thigmotaxis of larvae at the age of 7 dpf (Figure 3.9) The 
longest swimming distance (25.33 ± 6.01 cm) and the highest swimming speed (9.67 
± 1.55 cm/min) were both observed in larvae exposed to 0.1 mg/L BMAA (Figures 
3.9C-D). Larvae exposed to 20 mM NaHCO3 in dilution water (sC) swam 66.98 ± 
13.90% of distance and spent 69.29 ± 13.72% of time in the outer zone of Petri dish. 
Larvae exposed to 1 mg/L BMAA exhibited the highest thigmotaxis in both distance 
(95.56 ± 2.91%) and time (96.11 ± 2.46%) (Figures 3.9A-B). 
3.2 Discussion 
The 96 h toxicity tests revealed that BMAA was not acutely lethal to fathead 
minnow (juveniles: 96 h LC50 > 10,000 μg/L; larvae: 96 h LC50 > 10,000 μg/L) or 
zebrafish (larvae: 96 h LC50 > 10,000 μg/L). The 10-day zebrafish embryo-larvae 
toxicity test further proves the low lethality of BMAA by showing a 10-day LC50 > 
100 mg/L. The zebrafish embryo-larvae test also showed that BMAA 
non-significantly accelerated the hatching of embryos. BMAA did significantly affect 
heart rate but had little effect in the body length of zebrafish larvae. 
The high 10-day LC50 (> 100 mg/L) for BMAA found in this study is contrary 
to previous work reporting a 10-day LC50 of BMAA as low as 10 μg/L in the same 
zebrafish embryo model (Purdie et al., 2009a). Purdie and colleagues in their 
investigation used different dilution water (dechlorinated water: hardness 10.6 mg/L, 
alkalinity 31.3 mg/L and pH 8.2) and different bicarbonate donor (Na2CO3) compared 
to this study (Purdie et al., 2009b). However, the huge difference (> 10,000 times) 
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between two LC50 values acquired is still surprising. Besides, the onset time of 
BMAA exposure is earlier in this study (< 1 hpf) than the previous work (24 hpf), 
which should normally result in a higher lethality in zebrafish embryos (T.  
Braunbeck and Lammer, 2006). Purdie et al. (2009b) also reported a reduction in 
heart rate of embryos at 72 hpf. However, several other sub-lethal effects reported by 
them, including pericardial edema, abnormal spinal axis formation, clonus-like 
convulsions, and significant premature point of hatch, were not observed in this study. 
Despite a low acute lethality in zebrafish, BMAA influenced embryo-larvae 
behaviors, especially motor function related behaviors. Spontaneous contractions are 
the first behavior of zebrafish embryos during their development. This movement is 
driven by simple electrical coupling of motor neurons in the spinal cord, independent 
of supraspinal inputs (Saint-Amant and Drapeau, 1998). That BMAA caused an 
earlier onset of spontaneous contractions, indicates a BMAA-induced earlier 
development of motor nervous system in zebrafish embryos. The frequency of 
embryonic spontaneous contractions has been shown to be affected by toxicants such 
as perfluorooctanesulphonicacid (PFOS) and chlorpyrifos (Huang et al., 2010; 
Selderslaghs et al., 2010). In contrast, BMAA as a neurotoxin had little influence on 
the frequency of spontaneous contractions at 22 hpf. However, at 27 hpf, BMAA 
showed a significant enhancement in the embryos’ touch-evoked contractions. Unlike 
the spontaneous movement stage when the formation of glutamate receptors just starts 
(Cox et al., 2005; Hoppmann et al., 2008), touch response of zebrafish embryos 
appears only after the glutamatergic synapses gradually take over the 
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neurotransmission between spinal motor network and sensory neurons as well as 
interneurons (Pietri et al., 2009). A significant amount of evidence supports the 
hypotheiss that BMAA is an agonist for many glutamate receptors such as NMDA, 
AMPA and mGluR5 (Chiu et al., 2012; Goto et al., 2012; Liu et al., 2009; Lobner et 
al., 2007). This indicates that the increase in touch response might result from the 
BMAA-induced hyperactivity of motor network. The involvement of glutamate 
receptors in the neurotoxicity of BMAA might also explain why touch-evoked 
contractions but not spontaneous contractions were influenced by BMAA.  
The adverse behavioral effect of BMAA was first observed in touch-evoked 
swimming activity of zebrafish embryos at 48 hpf. The significantly fewer responses 
and shorter (though not significant) escaping distances indicated that BMAA caused 
impairment of locomotor functions in embryos. Declined locomotor activity was also 
found in the free swimming of larvae at 144 hpf. The reduction in swimming distance 
and speed of larvae exposed to 1-100 mg/L BMAA agrees with the increase in the 
incidence of freezing points and the freezing time. Although larvae from higher 
BMAA concentration groups exhibited fewer erratic movements, it did not mean that 
they swam better in this case. This is because if a larva swims slowly all the time, its 
body might actually not be strong enough to perform continuous fast “beat and glide” 
movements. Thus, a lack of erratic swimming might refer to the weakness of motor 
function. It should be noted that larvae exposed to BMAA at the lower concentration 
(0.1 mg/L) seemed to have a higher (though not significant) swimming activity 
compared to sC. Interestingly, in the anxiety test, the longest swimming distance and 
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the fastest speed (though not significant) also belonged to larvae exposed to 0.1 mg/L 
BMAA. The pattern that BMAA enhances the swimming activity at a lower 
concentration but depresses the locomotion at a higher concentration is similar to 
what has been found in zebrafish treated with alcohol (Gerlai et al., 2000).  
The NMDA glutamatergic mediation appears to play an important role in the 
startle response of zebrafish (Caio Maximino et al., 2010b; Roberts et al., 2011). A 
previous study found that the NMDA receptor antagonist memantine increases the 
startle response (J. D. Best, et al., 2008). The reduction in startle response of larvae 
exposed to the NMDA receptor agonist BMAA is supported by previous results, 
consistent with a neurotoxic effect of BMAA exposure on zebrafish. No obvious 
change in the startle habituation of larvae indicates that the sensorimotor dysfunction 
rather than a faster habituation was mainly responsible for the reduction in the startle 
response.  
Due to the addition of 20 mM NaHCO3 as the bicarbonate donor for BMAA in 
the zebrafish embryo-larvae test, a NaHCO3 control group (sC) was necessary besides 
nC. However, from 48 hpf, embryos from the two control groups began to present 
obvious differences in locomotor activity. This suggests that the additional 20 mM 
NaHCO3 accelerates the development of embryos. Because no feeding was applied 
during the exposure, all nutrition acquired by embryo-larvae were via yolk sac 
absorption (Jardine and Litvak, 2003; Rubinstein, 2003). Therefore, the elevation of 
larvae’s locomotor activity in sC compared to nC might be attributed to sufficient 
minerals in test solution.  
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3.2.1 Conclusions 
(1) BMAA had a 96 h LC50 of over 10,000 μg/L to three test organisms: 1 
month juvenile fathead minnow, 12 dph larval fathead minnow and 72 hpf 
larval zebrafish. 
(2) BMAA showed a 10-day LC50 of higher than 100 mg/L to embryonic 
zebrafish (< 1 hpf). 
(3) BMAA exposure accelerated the heart rate of zebrafish embryos at 72 hpf, 
but reduced it at 144 hpf and 10 dpf. 
(4) BMAA exposure did not influence the body length of zebrafish larvae. 
(5) BMAA exposure induced an early onset of spontaneous contractions in 
zebrafish embryos. 
(6) BMAA exposure enhanced touch-evoked contractions of zebrafish 
embryos at 27 hpf. 
(7) BMAA depressed several locomotor activities of zebrafish embryo-larvae 
from 48 hpf to 7 dpf, including touch-evoked escape, free swimming and 
startle response. 
(8) BMAA did not cause anxiety in 7 dpf larval zebrafish. 
3.2.2 Importance and future work 
This is to our knowledge the first investigation into the behavioral effects of 
BMAA on fish. This study links motor dysfunctions in zebrafish embryo-larvae with 
BMAA, providing extra evidence of its neurotoxicity. The zebrafish embryo-larvae 
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model seems to be an ideal model of BMAA research because it provides rapid and 
diverse behavioral endpoints for neurotoxicity and neurodegeneration assessments (de 
Esch et al., 2012; Tierney, 2011). More investigations into the neurotoxicity of BMAA 
using this model are guaranteed in the future. This is also the first to study the acute 
toxicity of BMAA on fathead minnow. Although no behavioral endpoints were 
monitored in fathead minnow, its locomotor performance might also be influenced by 
BMAA. The finding that BMAA depresses touch-evoked escape, free swimming and 
startle response of fish is also of ecological importance, because these are all related 
to feeding and predator-related behaviors. Fish exposed to BMAA might have greater 
difficulty with respect to prey capture and predator avoidance. Due to the nature of an 
acute toxicity test, the BMAA concentrations selected in this study are much higher 
than the level detected in real aquatic environment (Al-Sammak et al., 2014; Faassen, 
2014). However, given the potential ubiquity of BMAA and its ability to 
bioaccumulate (Esterhuizen and Downing, 2008; Murch et al., 2004a), even BMAA at 
low concentrations in aquatic ecosystems might result in chronic toxic effects on fish 
and other aquatic organism. Future study is required to understand the fate of BMAA 
in aquatic ecosystems and its chronic effects on different aquatic organisms.  
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Figure 1.1. Chemical structure of BMAA. 
 
 
 
Figure 1.2 Comparison of the structure of L-BMAA-carbamate and L-glutamate 
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Figure 2.1. Distribution of test groups on 24-well plates in zebrafish embryo-larvae 
10-day LC50 test. 1 reperents 1 mg/L BMAA; 2 reperents 3 mg/L BMAA; 3 
reperents 10 mg/L BMAA; 4 reperents 30 mg/L BMAA; 5 reperents 100 mg/L 
BMAA; nC reperents negative control (dilution water); sC reperents solvent control 
(20 mM NaHCO3); and iC reperents internal plate control (dilution water). 
 
 
 
Figure 3.1. Hatching time of embryos exposed to nC (dilution water), sC (20 mM 
NaHCO3) or BMAA (1-100 mg/L) in sC. Bars represent the average value ± SEM per 
test group (n = 12). 
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Figure 3.2. Heart rate of embryos exposed to nC (dilution water), sC (20 mM 
NaHCO3) or BMAA (1-100 mg/L) in sC at (A) 72 hpf, (B) 144 hpf, and (C) 10 dpf. 
Bars represent the average value ± SEM per test group (
+
p < 0.05, 
++
p < 0.01, 
+++
p < 
0.001 vs nC; *p < 0.05, **p < 0.01, ***p < 0.001 vs sC; n = 10). 
 
 
    
Figure 3.3. Body length of embryos exposed to nC (dilution water), sC (20 mM 
NaHCO3) or BMAA (1-100 mg/L) in sC at (A) 144 hpf, and (B) 10 dpf. Bars 
represent the average value ± SEM per test group (n = 10). 
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Figure 3.4. (A) Onset time and (B) frequency of spontaneous contractions at 22 hpf 
for embryos exposed to sC (20 mM NaHCO3) or BMAA (1-100 mg/L) in sC. Bars 
represent the average value ± SEM per test group (**p < 0.01 vs sC; n = 10). 
 
 
 
Figure 3.5. Incidence of contractions in response to 10 touches for embryos exposed 
to sC (20 mM NaHCO3) or BMAA (1-100 mg/L) in sC at 27 hpf. Bars represent the 
average value ± SEM per test group (*p < 0.05 vs sC; n = 10). 
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Figure 3.6. (A) Incidence of escapes in response to 12 touches and (B) swimming 
distance during each escape for embryos exposed to sC (20 mM NaHCO3) or BMAA 
(1-100 mg/L) in sC at 48 hpf. Bars represent the average value ± SEM per test group 
(*p < 0.05, **p < 0.01 vs sC; n = 10). 
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Figure 3.7. (A) Total swimming distance, (B) swimming speed during movement, (C) 
incidence of freezing, (D) time spent in freezing and (E) incidence of erratic 
swimming for larvae exposed to sC (20 mM NaHCO3) or BMAA (1-100 mg/L) in sC 
at 144 hpf. Bars represent the average value ± SEM per test group (*p < 0.05, **p < 
0.01, ***p < 0.001 vs sC; n = 12). 
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Figure 3.8. Startle response to continual 20 taps for larvae exposed to sC (20 mM 
NaHCO3) or BMAA (1-100 mg/L) in sC at 168 hpf. The average swimming distance 
of larvae in 2 s after each tap was compared between sC and the (A) 0.1 mg/L, (B) 1 
mg/L, (C) 10 mg/L and (D) 100 mg/L BMAA groups, respectively. “ ” marks the 
beginning of taps. Data points represent the average value ± SEM per test group (*p < 
0.05, **p < 0.01, ***p < 0.001 vs sC; n = 10). (E) Average swimming distance over 
20 tap and (F) number of taps needed for startle habituation for larvae from different 
test groups. Bars represent the average value ± SEM per test group (*p < 0.05 vs sC; n 
= 10). 
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Figure 3.9. Thigmotaxis and swimming activity of larvae at the age of 7 dpf after 10 
min exposure to sC (20 mM NaHCO3) or BMAA (1-100 mg/L) in sC. (A) Percentage 
of distance larvae swam and (B) percentage of time larvae spent in outer zone of Petri 
dish. (C) Total swimming distance and (D) swimming speed during movements for 
larvae from different test groups. Bars represent the average value ± SEM per test 
group (n = 7). 
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